Company Filing History:
1 out of 3,688 
1 out of 2,012 
Years Active: 2017
Title: Innovations in Medulloblastoma Research: The Contributions of Donald Williams Parsons
Introduction: Donald Williams Parsons is a distinguished inventor based in Ellicott City, Maryland, known for his pivotal research in the field of oncology. With a focus on medulloblastoma, the most common malignant brain tumor in children, Parsons has made significant strides in understanding the genetic underpinnings of this condition. His contributions have the potential to enhance diagnostic methods and therapeutic strategies for combating this challenging pediatric cancer.
Latest Patents: Parsons holds a patent specifically titled "Medulloblastoma genes as targets for diagnosis and therapeutics." This innovative patent stems from rigorous research that highlights the genetic alterations present in medulloblastoma tumors. Utilizing high-density microarrays, Parsons and his team were able to identify mutation patterns that differ significantly from those found in adult cancers. His findings reveal that each medulloblastoma tumor typically presents with 11 gene alterations, a notable decrease compared to adult malignancies, emphasizing unique aspects of pediatric cancer biology.
Career Highlights: Throughout his career, Donald Williams Parsons has been affiliated with esteemed institutions such as The Johns Hopkins University and Duke University. His work has focused on identifying copy number alterations and sequencing proteins and miRNA genes relevant to medulloblastoma, shedding light on critical genetic factors that influence the disease. The discovery of inactivating mutations in histone methylation genes, such as MLL2 and MLL3, in 16% of medulloblastoma patients, exemplifies the importance of his research in understanding childhood tumors.
Collaborations: Parsons has collaborated with prominent figures in the research community, including Bert Vogelstein and Kenneth W. Kinzler. Their collaborative efforts have significantly advanced the understanding of genetic alterations and developmental pathways in childhood cancers, making a noteworthy impact on the science of oncology and paving the way for innovative therapeutic strategies.
Conclusion: Donald Williams Parsons stands out as a vital inventor in the realm of pediatric oncology, with a focused dedication to deciphering the complexities of medulloblastoma. His patented innovations not only contribute to scientific knowledge but also hold promise for improved diagnostic and therapeutic avenues for children affected by this disease. As research continues to unfold, Parsons’ work remains a cornerstone in the fight against childhood brain tumors.